About Taro Pharmaceutical Industries
Taro Pharmaceutical Industries is a publicly listed company based in Haifa (Israel) founded in 1950, and was acquired by Sun Pharma in September 2010. Taro Pharmaceutical Industries is engaged in developing and distributing pharmaceuticals. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. The company has 129 employees. Taro Pharmaceutical Industries has completed 4 acquisitions, including Alchemee, Antibe Thera and Aquinox Pharma. Its chief executive, as recorded, is Uday Baldota. Its website taro.com draws about 15 thousand monthly visits. Taro Pharmaceutical Industries offers products and services including Prescription Products and Over-the-Counter Products. Its focus areas include Pharmaceuticals and Generic Drugs. Its legal entity is Taro Pharmaceutical Industries Ltd.
Company details
Taro Pharmaceutical Industries is involved in the development, manufacturing, and distribution of prescription and over-the-counter pharmaceutical products. Operations are conducted across multiple regions including the USA, Canada, Israel, and other international markets. The company is focused on providing innovative therapies and generic medicines. As a subsidiary of Sun Pharma, a global healthcare company, Taro contributes to a broad portfolio of healthcare solutions addressing various medical needs in diverse sectors.
- Headquarters Haifa, Israel
- Employees 129
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website taro.com
- Social LinkedIn X
- Acquired by Sun Pharma (Sep 2010)
- Legal Name Taro Pharmaceutical Industries Ltd.
- Latest Funding Round$60M (USD), Debt – Conventional
May 2003
- Investors
- Employee Count129
- Investments & AcquisitionsAlchemee
& 3 more
- Acquired bySun Pharma
(Sep 2010)
Products & Services of Taro Pharmaceutical Industries
Taro Pharmaceutical Industries offers a comprehensive portfolio of products and services, including Prescription Products and Over-the-Counter Products.
Prescription drugs are developed for various medical conditions.
Over-the-counter medications are provided for common health issues.
Funding Insights of Taro Pharmaceutical Industries
- Total Rounds 1
- Last Round Debt – Conventional — $60M
- First Round $60M
(May 2003)
All 1 funding rounds of Taro Pharmaceutical Industries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2003 | $60M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Taro Pharmaceutical Industries
Taro Pharmaceutical Industries has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sun Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | sunpharma.com | Mumbai, India |
Investor details for Taro Pharmaceutical Industries
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Taro Pharmaceutical Industries
74 people are tracked at Taro Pharmaceutical Industries (16 in leadership, 5 in board & advisors, 53 in team); the tracked headcount is 129.
| Name | Role | Group |
|---|---|---|
Uday Baldota | CEO | Leadership |
Haim Schwartz | QA API Director | Leadership |
Raffaele Spadafora | Head Of Specialty Business | Leadership |
Boaz Leshem | AVP Head Of Manufacturing Operations | Leadership |
Rob Hooper | Director OTC Brand Sales | Leadership |
Olga Ben Ari | Director , Head Of IT | Leadership |
Michal Solan | Director, Corporate Design | Leadership |
Caitlin Wojacek | HR Business Partner | Leadership |
Keren Gonen Aberman | QA Director And QP | Leadership |
Chanchal Gupta | Associate Director Quality Compliance | Leadership |
Chriselda Gonsalves | Director, Quality Compliance | Leadership |
Michele V. | Group Vice President, Human Resources | Leadership |
Andreas Wegner | Vice President, Head Of Manufacturing - Site Head | Leadership |
Mona Bickler | Director, Learning And Organizational Development | Leadership |
Iris Melech | Head Of Economic Dep. | Leadership |
Iva Sola | Sr. Director, QA And Compliance | Leadership |
Linda Benshoshan | Director | Board & advisors |
Sudhir Valia | Director | Board & advisors |
Dilip Shanghvi | Chairman | Board & advisors |
Robert Stein | Director | Board & advisors |
54 more people are available in the full profile.
Complete people profiles for Taro Pharmaceutical Industries
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Taro Pharmaceutical Industries
Taro Pharmaceutical Industries has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alchemee, Antibe Thera and Aquinox Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutics for inflammation, pain, and vascular dysfunction are developed. | antibethera.com | Toronto, Canada | 2010 | Jan 2025 | $4.5M | |
Skin care products are manufactured under contract by Alchemee. | alchemee.com | El Segundo, United States | 2007 | Feb 2022 | $90M | |
Small molecule targeting PI3K pathway. | aqxpharma.com | Vancouver, Canada | 2004 | Jul 2020 | $8.2M | |
Therapeutics for STEC bacterial infections are developed. | thallion.com | Dorval, Canada | 2007 | Mar 2017 | $1.71M |
Complete acquisition details for Taro Pharmaceutical Industries
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Taro Pharmaceutical Industries
8 dated milestones of Taro Pharmaceutical Industries across 75 years, from founding to its latest funding, stage changes and deals.
- Founded Taro Pharmaceutical Industries is founded.
- Funding First funding round of $60.0M.
- Exit Acquired by Sun Pharma.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Thallion Pharmaceuticals.
- Acquisition Acquires Aquinox Pharma.
- Acquisition Acquires Alchemee.
- Acquisition Acquires Antibe Thera.
Web traffic of Taro Pharmaceutical Industries
The website of Taro Pharmaceutical Industries (taro.com) receives about 15.5K visits a month and ranks #1,759,703 among all websites worldwide, #2,390 in Biotechnology and Pharmaceuticals.
- Monthly visits15.5K
▲ 6.2% vs previous month
- Unique visitors6.3K
per month
- Global rank#1,759,703
among all websites
- Category rank#2,390
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.6
- Average visit17 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Taro Pharmaceutical Industries. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| perrigo.com | 100% | 61.1K | #524,398 | View details | |
| mylan.com | 94% | 26.4K | #1,585,141 | View details | |
| tevapharm.com | 92% | 166.9K | #278,209 | View details | |
| myriad.com | 90% | 205.3K | #109,684 | View details | |
| blairex.com | 89% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Taro Pharmaceutical Industries
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Taro Pharmaceutical Industries
Complete news archive for Taro Pharmaceutical Industries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taro Pharmaceutical Industries
Taro Pharmaceutical Industries was founded in 1950 and raised its 1st funding round 53 years after it was founded.
Taro Pharmaceutical Industries is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Uday Baldota is the CEO of Taro Pharmaceutical Industries, as recorded in our data.
Taro Pharmaceutical Industries has 129 employees.
Taro Pharmaceutical Industries is involved in the development, manufacturing, and distribution of prescription and over-the-counter pharmaceutical products. Operations are conducted across multiple regions including the USA, Canada, Israel, and other international markets. The company is focused on providing innovative therapies and generic medicines. As a subsidiary of Sun Pharma, a global healthcare company, Taro contributes to a broad portfolio of healthcare solutions addressing various medical needs in diverse sectors.
Taro Pharmaceutical Industries offers Prescription Products and Over-the-Counter Products.
Taro Pharmaceutical Industries has made 4 acquisitions, including Alchemee, Antibe Thera, and Aquinox Pharma.
Taro Pharmaceutical Industries has 1 investor. Key investors include Sun Pharma.
Taro Pharmaceutical Industries operates through Taro Pharmaceutical Industries Ltd..
Yes. Taro Pharmaceutical Industries was acquired by Sun Pharma in September 2010.